4//SEC Filing
Williams Richard Thomas 4
Accession 0001209191-22-018866
CIK 0001797768other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 5:01 PM ET
Size
7.4 KB
Accession
0001209191-22-018866
Insider Transaction Report
Form 4
Williams Richard Thomas
Chief Medical Officer
Transactions
- Purchase
Common Stock
2022-03-11$8.64/sh+15,000$129,600→ 17,333 total - Purchase
Common Stock
2022-03-14$8.37/sh+25,000$209,250→ 42,333 total
Footnotes (3)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.42 to $8.77, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
- [F2]Includes 1,769 shares acquired under the Issuers Employee Stock Purchase Plan (the "Plan") in May 2021 and 564 shares acquired under the Plan in November 2021.
- [F3]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.25 to $8.50, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
Documents
Issuer
Kinnate Biopharma Inc.
CIK 0001797768
Entity typeother
Related Parties
1- filerCIK 0001825148
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 5:01 PM ET
- Size
- 7.4 KB